This inventor holds 3 USPTO granted patents. Top assignees: University of Pennsylvania, Other. Active years: 2001-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2001-2012
Title: The Innovations of Joel Rosenbloom
Introduction
Joel Rosenbloom is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of biotechnology, particularly in the area of cell calcification. With a total of 3 patents to his name, his work has the potential to impact various medical applications.
Latest Patents
Rosenbloom's latest patents focus on cell calcification suppressing proteins and the genes that encode these proteins. His invention provides cell-calcification inhibitory proteins, which are crucial for preventing unwanted calcification in cells. This innovation is based on the discovery of a novel isoform gene of the c-erg gene, referred to as the 'C-11 gene', which is derived from chickens. The nucleotide sequence of the C-11 gene has been determined, and the expression of the protein it encodes, known as the 'C-11 protein', has been confirmed. Notably, it has been discovered that introducing the c-erg or C-11 gene into osteoblasts inhibits the calcification of these cells.
Career Highlights
Throughout his career, Joel Rosenbloom has worked with prestigious institutions, including the University of Pennsylvania. His research has contributed to advancements in understanding cell behavior and the mechanisms behind calcification.
Collaborations
Rosenbloom has collaborated with notable colleagues such as Masahiro Iwamoto and Yoshinobu Higuchi. Their combined expertise has furthered the research in the field of cell calcification and its implications.
Conclusion
Joel Rosenbloom's innovative work in cell calcification and his contributions to biotechnology highlight the importance of research in developing solutions for medical challenges. His patents and collaborations reflect a commitment to advancing scientific knowledge and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile